![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
Previous Article | Next Article 
Journal of Clinical Microbiology, September 2006, p. 3401-3404, Vol. 44, No. 9
0095-1137/06/$08.00+0 doi:10.1128/JCM.00611-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Dipartimento di Genetica e Microbiologia, Università di Bari, Via G. Amendola 165/A, 70126 Bari, Italy,1 Interuniversity Research Center for Sustainable Development, Università "La Sapienza," Palazzo Doria Pamphilj, 00038 Valmontone, Roma, Italy,2 African Medical and Research Foundation (AMREF), P.O. Box 30125, Nairobi, Kenya,3 Unité de Biodiversité des Bactéries Pathogènes Emergentes, Institut Pasteur, 75724 Paris Cedex 15, France4
Received 22 March 2006/ Returned for modification 9 May 2006/ Accepted 17 July 2006
 |
ABSTRACT |
|---|
 Top Abstract TextReferences |
|---|
|
TEXT |
|---|
|
TopAbstractTextReferences |
|---|
Since 1971, Kenya has suffered several waves of cholera recrudescence. Its largest epidemic started in 1997 (14), with 17,200 cases notified to the WHO. In 1998 and 1999, the epidemic progressed with more than 33,400 notified cases. The final official figures of the Kenyan epidemic were 10% of all cholera cases reported from the African continent in the same 3 years (14, 17, 18).
In this paper, we present phenotypic and genotypic features of 80 V. cholerae O1 strains representative of the 1998-to-1999 period of the epidemic occurring in Kenya. Strains were characterized by PCR detection of phage CTX
genes and pathogenicity genes, BglI ribotyping, antimicrobial susceptibility testing, and a random amplified polymorphic DNA (RAPD) assay.
Collection and identification of isolates. Eighty strains were selected among V. cholerae O1 isolates collected from 29 outbreaks in different provinces of Kenya in 1998 and 1999 (Table 1; Fig. 1). The strains were isolated from rectal swabs in Cary-Blair transport medium as described previously (8). All strains were biotype El Tor, 57 were serotype Ogawa, and 23 were serotype Inaba. Original stock cultures of isolates were kept in 20% glycerol Luria-Bertani broth at –70°C.
|
|
genes and pathogenicity genes.
Detection of genes encoding cholera toxin subunit A (ctxA), zonula occludens toxin (zot), accessory cholera enterotoxin (ace), and toxin-coregulated pilus for intestinal colonization (tcpA) was performed by PCR as described previously (10, 16). A negative control (reaction mixture without template) and a toxin-positive control (V. cholerae O1 strain O395) were also included. Of 80 strains, 77 were PCR positive for genes ctxA, zot, ace, and tcpA, 2 strains were negative for gene tcpA, and 1 was negative for gene zot. Ribotyping. Molecular characterization by BglI restriction patterns of 16S and 23S rRNA genes was performed as described previously (4, 6, 7, 11). On the basis of the restriction patterns observed, the 80 Kenyan strains of V. cholerae O1 could be divided into two groups. The first group was composed of 61 strains showing the standard reference pattern of ribotype B27 (57 strains) or of its subtypes (4 strains from Kajiado District) (Table 1). The second group (North Eastern Province) contained 19 strains belonging to ribotypes B5a (10 strains), B8a (8 strains), and B21a (1 strain) (Table 1).
The 61 strains of ribotype B27 represented 25 local outbreaks that had occurred in different districts scattered around the entire country (Fig. 1), whereas the 19 strains of ribotypes B5a, B8a, and B21a were from 4 outbreaks all localized in North Eastern Province, which lies along the Somalia border. Moreover, in the 1990s, ribotypes B5a, B8a, and B21a were systematically prevalent in focuses in Somalia where V. cholerae is endemic and epidemic (unpublished results).
These data indicated that ribotype pattern B27 was a distinguishing molecular character of the most widely distributed V. cholerae O1 strains responsible for the epidemic in Kenya.
Antimicrobial susceptibility. Antimicrobial susceptibility was determined by the disk diffusion method as described previously (2, 13). The antimicrobial disks were used at the following concentrations: 10 µg ampicillin (AMP), 30 µg chloramphenicol (CHL), 30 µg doxycycline (DOX), 30 µg kanamycin, 10 µg spectinomycin (SPT), 10 µg streptomycin (STR), 25 µg sulfamethoxazole (SMX), 30 µg tetracycline (TET), and 5 µg trimethoprim (TMP).
Escherichia coli ATCC 25922 was used as a quality control strain. Genetic techniques for conjugation and incompatibility testing were the same as those used previously (2).
The 61 strains of ribotype B27 were resistant to CHL, SPT, STR, SMX, and TMP; 6 of them, isolated from areas on the shore of Lake Victoria (Table 1; Fig. 1), were also resistant to DOX and TET. These additional resistances were due to the presence of a conjugative plasmid belonging to incompatibility class C and encoding resistance to DOX, SMX, and TET. Acquisition of this plasmid by a ribotype B27 strain resistant to CHL, SPT, STR, SMX, and TMP was the most probable and simple event for explaining the origin of this Lake Victoria group of TET-resistant strains.
The 19 strains of ribotypes different from B27 exhibited two resistance patterns. The 12 strains of ribotypes B5a, B8a, and B21a from Mandera District (Fig. 1) were resistant to SPT and susceptible to all the other antimicrobials tested independent of ribotype. The seven strains of ribotype B8a from Garissa District were resistant to AMP, CHL, SPT, STR, SMX, and TMP. These resistance patterns corresponded to the two prevalent patterns identified in V. cholerae O1 strains in Somalia in the 1990s (unpublished results).
RAPD assay.
Genomic DNA extraction and PCRs were performed as described previously (9). Each strain was characterized by the combination (cluster type) of six RAPD patterns (Fig. 2) generated by six single primers selected from enterobacterial repetitive intergenic consensus sequences (ERIC1 and ERIC2), from V. cholerae repetitive sequences (VCR1 and VCR2), and from phage CTX sequences (ATX1 and ATX2). Combinations with six identical amplified DNA patterns or with one different amplicon in only one pattern out of the six were classified in the same specific RAPD cluster type.
|
The 61 strains of ribotype B27 were all classified as RAPD cluster type IV whose reference combination was E5/E12/V2/V5/A1/A8 (Fig. 2). Fifty-five strains produced the exact reference combination, and six strains, all of the Lake Victoria group (Table 1), produced cluster E6/E12/V2/V5/A1/A8 (three strains) and cluster E6/E12/V1/V5/A1/A8 (three strains). The difference between patterns E5 and E6 consisted in one band at 1.2 kb (Fig. 2) associated with the IncC DOX-SMX-TET resistance plasmid. Lake Victoria strains cured of the plasmid shifted from pattern E6 to pattern E5. In comparison with pattern V2, pattern V1 contained one more band at 1.9 kb. The genetic nature of that variation remains unexplained.
The 12 strains of ribotypes B5a, B8a, and B21a from Mandera District and the 7 strains of ribotype B8a from Garissa District had clusters E1/E12/V2/V5/A28/A8 and E2/E14/V2/V5/A2/A8, respectively. These two combinations were distinct (Fig. 2) from those of RAPD cluster type IV and belonged to two different cluster types, VII and VIII.
Characterization of 80 strains of V. cholerae O1 isolated during the Kenyan epidemic in 1998 and 1999 demonstrated that 61 strains were ribotype B27, showed an identical and stable multiple resistance to CHL, SPT, STR, SMX, and TMP, and produced the same cluster type of six random amplified DNA patterns. This uniformity of properties and the fact that the 61 strains examined were representative of 25 outbreaks (out of 29 investigated) occurring in districts scattered over the entire area of the country (Fig. 1) provided strong genetic and epidemiological evidence that the predominant strains causing the epidemic had a clonal origin. Identification of 19 strains, with traits typical of V. cholerae O1 strains active in Somalia, from four outbreaks in North Eastern Province indicated that province as an epidemic zone where the Kenyan clone and Somali strains were overlapping and presumably competing.
Ribotype B27 was first identified in Calcutta in 1993 and introduced into the western African country of Guinea-Bissau in 1994 (3, 15). In 1995 and 1996, ribotype B27 was identified among V. cholerae O1 strains, causing cholera outbreaks in Senegal (1). Our findings suggest that this emerging ribotype has had a rapid spread into eastern Africa.
|
ACKNOWLEDGMENTS |
|---|
We thank Nicola Pugliese for technical assistance.
|
FOOTNOTES |
|---|
|
REFERENCES |
|---|
|
TopAbstractTextReferences |
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|
